###
中国临床研究:2026,39(9):1427-1432
本文二维码信息
码上扫一扫!
铁代谢指标对2型糖尿病合并非酒精性脂肪性肝病进展的预测价值
(1. 南通市第二人民医院内分泌代谢科,江苏 南通 226002;2. 南通市第二人民医院临床营养科,江苏 南通 226002)
Predictive value of iron metabolism indicators for the progression of non-alcoholic fatty liver disease in patients with type 2 diabetes mellitus
摘要
本文已被:浏览 274次   下载 310次
投稿时间:2026-01-19   网络发布日期:2026-09-24
中文摘要: 目的  探讨铁代谢指标与2型糖尿病(T2DM)合并非酒精性脂肪性肝病(NAFLD)患者疾病严重程度的关系,并评估其对NAFLD 进展为非酒精性脂肪性肝炎(NASH)的预测价值。方法  采用回顾性研究设计,纳入2022 年5 月至2025 年5 月南通市第二人民医院收治的180 例T2DM 合并NAFLD 患者作为研究对象。所有患者均接受肝脏磁共振质子密度脂肪分数(MRI-PDFF)检测,根据MRI-PDFF及肝纤维化指数-4(FIB-4),将患者分为NASH高危组(MRI-PDFF≥5%,且FIB-4≥1.3)和单纯性脂肪肝组(MRI-PDFF≥5%,且FIB-4<1.3)。收集患者的临床资料及铁代谢指标相关资料[血清铁(SI)、铁蛋白(SF)、总铁结合力(TIBC)、转铁蛋白饱和度(TSAT)]。采用多因素logistic回归分析NAFLD进展的影响因素,并通过受试者工作特征(ROC)曲线评估各指标对NAFLD进展的预测价值。结果  在180 例患者中,112 例(62.22%)为NASH 高危组,68 例(37.78%)为单纯性脂肪肝组。与单纯性脂肪肝组比较,NASH高危组患者的SI、SF、TSAT、稳态模型评估胰岛素抵抗指数(HOMA-IR)及血清丙氨酸氨基转移酶水平更高(P<0.05),TIBC水平更低(P<0.05)。多因素logistic回归分析显示,SI(OR=1.966,95%CI:1.212~3.190)、SF(OR=2.085,95%CI:1.145~3.799)、TSAT(OR=1.820,95%CI:1.139~2.908)及HOMA-IR(OR=2.024,95%CI:1.185~3.456)高是NAFLD 进展的独立危险因素(P<0.05)。ROC 曲线分析显示,SI、SF、TSAT 三项指标联合预测NAFLD 进展的ROC 曲线下面积(AUC)为0.868(95%CI:0.810~0.914),高于各指标单独检测[SI:AUC=0.701(95% CI:0.628~0.767),Z=3.378,P<0.05;SF:AUC=0.781(95% CI:0.713~0.839),Z=1.930,P<0.05;TSAT:AUC=0.702(95%CI:0.629~0.767),Z=2.905,P<0.05],此时联合检测的灵敏度及特异度分别为84.82%和88.24%。结论  铁代谢紊乱与T2DM 合并NAFLD 患者的疾病进展密切相关,SI、SF 及TSAT 是疾病进展的独立影响因素,三者联合检测对NAFLD进展为NASH有较高的预测效能。
Abstract:Objective To investigate the relationship between iron metabolism indicators and disease severity in type 2 diabetes mellitus(T2DM)patients complicated with non-alcoholic fatty liver disease(NAFLD),and to evaluate their predictive value for the progression of NAFLD to non-alcoholic steatohepatitis(NASH). Methods A retrospective study was conducted,enrolling 180 patients with T2DM and NAFLD who were admitted to the Second People's Hospital of Nantong from May 2022 to May 2025. All patients underwent hepatic magnetic resonance imaging-proton density fat fraction(MRI-PDFF)measurement. Based on MRI-PDFF,and the Fibrosis-4 Index(FIB-4),patients were divided into the high-risk NASH group(MRI-PDFF ≥5% and FIB-4 ≥1.3)and the simple hepatic steatosis group(MRI-PDFF ≥5% and FIB-4<1.3). Clinical data and iron metabolism parameters,including serum iron(SI),ferritin(SF),total iron-binding capacity(TIBC),and transferrin saturation(TSAT),were collected. Multivariate logistic regression analysis was used to identify factors influencing NAFLD progression,and receiver operating characteristic(ROC)curves were employed to evaluate the predictive value of each indicator and their combination. Results Among the 180 patients,112(62.22%)were classified into the high - risk NASH group and 68(37.78%)into the simple hepatic steatosis group. Compared with the simple hepatic steatosis group,patients in the high - risk NASH group had significantly higher levels of SI,SF,TSAT,Homeostasis Model Assessment of Insulin Resistance(HOMA-IR),and serum alanine aminotransferase(P<0.05),and lower TIBC levels(P<0.05). Multivariate logistic regression analysis revealed that high SI(OR=1.966,95%CI:1.212-3.190),SF(OR=2.085,95%CI:1.145-3.799),TSAT(OR=1.820,95%CI:1.139-2.908),and HOMA-IR(OR=2.024,95%CI:1.185-3.456)were independent risk factors for NAFLD progression(P<0.05). ROC curve analysis showed that the combination of SI,SF,and TSAT yielded an area under the curve(AUC)of 0.868(95%CI:0.810-0.914)for predicting NAFLD progression,which was higher than that of each individual indicator[SI:AUC=0.701(95% CI:0.628- 0.767),Z=3.378,P<0.05;SF:AUC=0.781(95% CI:0.713-0.839),Z=1.930,P<0.05;TSAT:AUC=0.702(95%CI:0.629-0.767),Z=2.905,P<0.05],with a sensitivity of 84.82%and a specificity of 88.24%. Conclusion Iron metabolism disorders are closely associated with disease progression in patients with T2DM and NAFLD. SI,SF,and TSAT are independent influencing factors for disease progression,and their combined detection demonstrates high predictive efficacy for the progression of NAFLD to NASH.
文章编号:     中图分类号:R589.2 R587.1    文献标志码:A
基金项目:江苏省卫生健康委员会医学科研面上项目(M2024163);南通市卫生健康委员会面上课题(MS2025045)
附件
引用文本:
成殷勤,陈红梅,李洪彬,等.铁代谢指标对2型糖尿病合并非酒精性脂肪性肝病进展的预测价值[J].中国临床研究,2026,39(9):1427-1432.

用微信扫一扫

用微信扫一扫